60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals EPS Diluted (Quarterly) : -0.903 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.903 |
| March 31, 2026 | -1.280 |
| December 31, 2025 | -1.348 |
| September 30, 2025 | -2.659 |
| June 30, 2025 | -5.005 |
| March 31, 2025 | -1.562 |
| December 31, 2024 | -15.38 |
| September 30, 2024 | -0.9299 |
| June 30, 2024 | -84.50 |
| Date | Value |
|---|---|
| March 31, 2024 | 7.318 |
| December 31, 2023 | -4.290 |
| September 30, 2023 | 8.640 |
| June 30, 2023 | -6.891 |
| March 31, 2023 | -5.370 |
| September 30, 2022 | -59.79 |
| March 31, 2022 | -1.884 |
| December 31, 2021 | -2.811 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Harrow, Inc. | -0.4624 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.263M |
| Revenue (Quarterly) | 0.2079M |
| Total Expenses (Quarterly) | 2.470M |
| Enterprise Value | 11.48M |
| Gross Profit Margin (Quarterly) | 27.32% |
| Profit Margin (Quarterly) | -1.09K% |
| Earnings Yield | -573.1% |
| Normalized Earnings Yield | -594.88 |